HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anaphylaxis.

AbstractBACKGROUND:
Anaphylaxis is the quintessential critical illness in emergency medicine. Symptoms are rapid in onset and death can occur within minutes. Approximately 1500 patients die annually in the United States from this deadly disorder. It is imperative, therefore, that emergency care providers be able to diagnose and appropriately treat patients with anaphylaxis. Any delays in recognition or initiation of therapy can result in unnecessary increases in patient morbidity and mortality.
DISCUSSION:
Recent literature, including updated international anaphylaxis guidelines, has improved our understanding and management of this critical illness. Anaphylaxis is a multisystem disorder that can manifest signs and symptoms related to the cutaneous, respiratory, cardiovascular, and gastrointestinal systems. Epinephrine remains the drug of choice and should initially be administered intramuscularly, into the anterolateral thigh, as soon as the diagnosis is suspected. For patients unresponsive to repeated intramuscular injections, a continuous infusion of epinephrine should be started. Antihistamines and corticosteroids are second-line medications and should never be given in lieu of, or prior to, epinephrine. Aggressive fluid resuscitation should also be used to treat the intravascular volume depletion characteristic of anaphylaxis. Patient observation and disposition should be individualized, as there is no well-defined period of observation after resolution of signs and symptoms.
CONCLUSIONS:
For patients with anaphylaxis, rapid and appropriate administration of epinephrine is critical for survival. Additional therapy, such as supplemental oxygen, intravenous fluids, antihistamines, and corticosteroids should not delay the administration of epinephrine.
AuthorsJeffrey Zilberstein, Michael T McCurdy, Michael E Winters
JournalThe Journal of emergency medicine (J Emerg Med) Vol. 47 Issue 2 Pg. 182-7 (Aug 2014) ISSN: 0736-4679 [Print] United States
PMID24881890 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • Adrenal Cortex Hormones
  • Bronchodilator Agents
  • Histamine Antagonists
  • Epinephrine
Topics
  • Adrenal Cortex Hormones (therapeutic use)
  • Anaphylaxis (diagnosis, etiology, therapy)
  • Bronchodilator Agents (administration & dosage)
  • Emergency Medicine (methods)
  • Epinephrine (administration & dosage)
  • Fluid Therapy (methods)
  • Histamine Antagonists (therapeutic use)
  • Humans
  • Resuscitation (methods)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: